Canopy Growth Corporation (NASDAQ:CGC) shares rose after the company announced it received EU GMP certification for its cannabis cultivation facility in Ontario. This certification allows the company to continue exporting medically certified cannabis to European and other global medical cannabis markets. The certification also marks the completion of Canopy's consolidation of its production footprint into two purpose-built sites.